The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States
Authors:
- 3 December 2019
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 171 (11) , 785-795
Abstract
The authors created a computer model to examine whether cognitive behavioral therapy or a second-generation antidepressant provides better health economic value for major depressive disorder. Visual Cost-Effectiveness of Cognitive Behavioral Therapy Versus Antidepressants The authors created a computer model to examine whether cognitive behavioral therapy or a second-generation... Background: Most guidelines for major depressive disorder recommend initial treatment with either a second-generation antidepressant (SGA) or cognitive behavioral therapy (CBT). Although most trial...Keywords
Funding Information
- U.S. Department of Veterans Affairs (CD2 07-206, IIR 10-176, IIR 14-324)
This publication has 64 references indexed in Scilit:
- The effects of psychotherapy for adult depression on suicidality and hopelessness: A systematic review and meta-analysisJournal of Affective Disorders, 2013
- Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic reviewCost Effectiveness and Resource Allocation, 2012
- Impact of Distance and Facility of Initial Diagnosis on Depression TreatmentHealth Services Research, 2011
- Cost-effectiveness of therapist-delivered online cognitive–behavioural therapy for depression: randomised controlled trialThe British Journal of Psychiatry, 2010
- Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland☆Journal of Affective Disorders, 2010
- Assigning Resources to Health Care Use for Health Services ResearchMedical Care, 2009
- Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: a randomized clinical trial, posttreatment outcomes, and six‐month follow‐upJournal of Clinical Psychology, 2008
- A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorderJournal of Psychopharmacology, 2008
- Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression.Journal of Consulting and Clinical Psychology, 2008
- Primary Care Physician Office Visits for Depression by Older AmericansJournal of General Internal Medicine, 2006